“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16zTechCrunch·20 hours agoBIB-5.49%BIS+5.55%
4basebio signs strategic collaboration, marketing agreement with Genezen on synthetic DNA for viral vectorsPUBT·Aug 26 at 01:07 AM
Valerio Therapeutics signs deal to buy Etherna Immunotherapies for €30 million enterprise valuePUBT·Aug 24 at 01:00 AM
OMNIAB INC C/WTS (TO PUR COM) | 8-K: FY2026 Q2 Revenue: USD 13.42 MEarnings Watch·Aug 6 at 03:50 PMOABIW0.00%
OMNIAB INC C/WTS (TO PUR COM) | 8-K: FY2026 Q1 Revenue: USD 14.43 MEarnings Watch·May 7 at 03:30 PMOABIW0.00%
OMNIAB INC C/WTS (TO PUR COM) | 10-K: FY2025 Revenue: USD 18.67 MEarnings Watch·Mar 4 at 03:43 PMOABIW0.00%
OMNIAB INC C/WTS (TO PUR COM) | 8-K: FY2025 Revenue: USD 18.67 MEarnings Watch·Mar 4 at 03:15 PMOABIW0.00%
OMNIAB INC C/WTS (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 2.239 MEarnings Watch·Nov 4, 2025 at 04:08 PMOABIW0.00%
OMNIAB INC C/WTS (TO PUR COM) | 8-K: FY2025 Q3 Revenue: USD 2.239 MEarnings Watch·Nov 4, 2025 at 03:33 PMOABIW0.00%
OMNIAB INC C/WTS (TO PUR COM) | 10-Q: FY2025 Q2 Revenue: USD 3.897 MEarnings Watch·Aug 6, 2025 at 03:43 PMOABIW0.00%
OMNIAB INC C/WTS (TO PUR COM) | 8-K: FY2025 Q2 Revenue: USD 3.897 MEarnings Watch·Aug 6, 2025 at 03:10 PMOABIW0.00%
OMNIAB INC C/WTS (TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 4.154 MEarnings Watch·May 8, 2025 at 03:53 PMOABIW0.00%
OMNIAB INC C/WTS (TO PUR COM) | 8-K: FY2025 Q1 Revenue: USD 4.154 MEarnings Watch·May 8, 2025 at 03:13 PMOABIW0.00%
